Carboplatin

FDA Approved: * October 14, 2004
Pharm Company: * BEDFORD
Category: Cancer

Carboplatin, sold under the trade name Paraplatin among others, is a chemotherapy medication used to treat a number of forms of cancer.[1] This includes ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma.[1] It is used by injection into a vein.[1] Side effects generally occur.[1] Common side effects include low blood cell levels, nausea, and electrolyte problems.[2][1 ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Carboplatin 10 mg/ml Intravenous Injection
NDC: 0703-3249
Labeler:
Teva Parenteral Medicines, Inc.
Carboplatin 10 mg/ml Intravenous Injection, Solution
NDC: 0703-4239
Labeler:
Teva Parenteral Medicines, Inc.
Carboplatin 10 mg/ml Intravenous Injection, Solution
NDC: 0703-4244
Labeler:
Teva Parenteral Medicines, Inc.
Carboplatin 10 mg/ml Intravenous Injection, Solution
NDC: 0703-4246
Labeler:
Teva Parenteral Medicines, Inc.
Carboplatin 10 mg/ml Intravenous Injection, Solution
NDC: 0703-4248
Labeler:
Teva Parenteral Medicines, Inc.
Carboplatin 10 mg/ml Intravenous Injection
NDC: 16729-295
Labeler:
Accord Healthcare, Inc.
Carboplatin 10 mg/ml Intravenous Injection, Solution
NDC: 25021-202
Labeler:
Sagent Pharmaceuticals
Carboplatin 10 mg/ml Intravenous Injection
NDC: 47335-150
Labeler:
Sun Pharma Global Fze
Carboplatin 10 mg/ml Intravenous Injection
NDC: 47335-151
Labeler:
Sun Pharma Global Fze
Carboplatin 10 mg/ml Intravenous Injection
NDC: 47335-284
Labeler:
Sun Pharma Global Fze

Related Brands

Drugs with the same active ingredients